Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib

Jennifer A. Woyach, Daniel Jones, Wojciech Jurczak, Tadeusz Robak, Árpád Illés, Arnon P. Kater, Paolo Ghia, John C. Byrd, John F. Seymour, Susan Long, Nehad Mohamed, Samon Benrashid, Tzung-Huei Lai, Gary De Jesus, Richard Lai, Gerjan de Bruin, Simon Rule, Veerendra Munugalavadla

Open source

DOI: 10.1182/blood.2023023659
Published: 2024-09-05
Container: Blood
Publisher: American Society of Hematology
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2023023659,
  title = {Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib},
  author = {Jennifer A. Woyach and Daniel Jones and Wojciech Jurczak and Tadeusz Robak and Árpád Illés and Arnon P. Kater and Paolo Ghia and John C. Byrd and John F. Seymour and Susan Long and Nehad Mohamed and Samon Benrashid and Tzung-Huei Lai and Gary De Jesus and Richard Lai and Gerjan de Bruin and Simon Rule and Veerendra Munugalavadla},
  year = {2024},
  journal = {Blood},
  doi = {10.1182/blood.2023023659},
  url = {https://doi.org/10.1182/blood.2023023659}
}

RIS

TY  - JOUR
TI  - Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib
AU  - Jennifer A. Woyach
AU  - Daniel Jones
AU  - Wojciech Jurczak
AU  - Tadeusz Robak
AU  - Árpád Illés
AU  - Arnon P. Kater
AU  - Paolo Ghia
AU  - John C. Byrd
AU  - John F. Seymour
AU  - Susan Long
AU  - Nehad Mohamed
AU  - Samon Benrashid
AU  - Tzung-Huei Lai
AU  - Gary De Jesus
AU  - Richard Lai
AU  - Gerjan de Bruin
AU  - Simon Rule
AU  - Veerendra Munugalavadla
PY  - 2024
JO  - Blood
DO  - 10.1182/blood.2023023659
UR  - https://doi.org/10.1182/blood.2023023659
ER  -

APA

Woyach, J. A., Jones, D., Jurczak, W., Robak, T., Illés, Á., Kater, A. P., Ghia, P., Byrd, J. C., Seymour, J. F., Long, S., Mohamed, N., Benrashid, S., Lai, T., Jesus, G. D., Lai, R., Bruin, G. D., Rule, S., & Munugalavadla, V. (2024). Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib. Blood. https://doi.org/10.1182/blood.2023023659

Source records

crossref · retrieved 2026-09-26T12:55:50.374Z